190 related articles for article (PubMed ID: 31617054)
21. EVI1 dysregulation: impact on biology and therapy of myeloid malignancies.
Birdwell C; Fiskus W; Kadia TM; DiNardo CD; Mill CP; Bhalla KN
Blood Cancer J; 2021 Mar; 11(3):64. PubMed ID: 33753715
[TBL] [Abstract][Full Text] [Related]
22. EVI‑1 acts as an oncogene and positively regulates calreticulin in breast cancer.
Wu L; Wang T; He D; Li X; Jiang Y
Mol Med Rep; 2019 Mar; 19(3):1645-1653. PubMed ID: 30592274
[TBL] [Abstract][Full Text] [Related]
23. MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma.
Liu YS; Lin HY; Lai SW; Huang CY; Huang BR; Chen PY; Wei KC; Lu DY
Oncogene; 2017 Aug; 36(35):5006-5022. PubMed ID: 28459461
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of MGMT methylation and expression of MGMT, P53, EGFR, MDM2 and PTEN in glioblastoma multiforme.
Limam S; Missaoui N; Abdessayed N; Mestiri S; Selmi B; Mokni M; Yacoubi MT
Ann Biol Clin (Paris); 2019 Jun; 77(3):307-317. PubMed ID: 31131831
[TBL] [Abstract][Full Text] [Related]
25. NFкB is a critical transcriptional regulator of atypical cadherin FAT1 in glioma.
Srivastava C; Irshad K; Gupta Y; Sarkar C; Suri A; Chattopadhyay P; Sinha S; Chosdol K
BMC Cancer; 2020 Jan; 20(1):62. PubMed ID: 31992226
[TBL] [Abstract][Full Text] [Related]
26. Epidermal Growth Factor (EGF) Augments the Invasive Potential of Human Glioblastoma Multiforme Cells via the Activation of Collaborative EGFR/ROS-Dependent Signaling.
Pudełek M; Król K; Catapano J; Wróbel T; Czyż J; Ryszawy D
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443749
[TBL] [Abstract][Full Text] [Related]
27. Treatment of glioblastoma multiforme using a combination of small interfering RNA targeting epidermal growth factor receptor and β-catenin.
Wang K; Park JO; Zhang M
J Gene Med; 2013 Jan; 15(1):42-50. PubMed ID: 23319157
[TBL] [Abstract][Full Text] [Related]
28. Elevated expression of Notch-1 and EGFR induced apoptosis in glioblastoma multiforme patients.
Xing ZY; Sun LG; Guo WJ
Clin Neurol Neurosurg; 2015 Apr; 131():54-8. PubMed ID: 25704190
[TBL] [Abstract][Full Text] [Related]
29. MUC4 modulates human glioblastoma cell proliferation and invasion by upregulating EGFR expression.
Li W; Wu C; Yao Y; Dong B; Wei Z; Lv X; Zhang J; Xu Y
Neurosci Lett; 2014 Apr; 566():82-7. PubMed ID: 24582898
[TBL] [Abstract][Full Text] [Related]
30. The tumor suppressor FOXO3a mediates the response to EGFR inhibition in glioblastoma cells.
Ramis G; Villalonga-Planells R; Serra-Sitjar M; Brell M; Fernández de Mattos S; Villalonga P
Cell Oncol (Dordr); 2019 Aug; 42(4):521-536. PubMed ID: 30980364
[TBL] [Abstract][Full Text] [Related]
31. Selective coexpression of VEGF receptor 2 in EGFRvIII-positive glioblastoma cells prevents cellular senescence and contributes to their aggressive nature.
Jones KA; Gilder AS; Lam MS; Du N; Banki MA; Merati A; Pizzo DP; VandenBerg SR; Gonias SL
Neuro Oncol; 2016 May; 18(5):667-78. PubMed ID: 26420897
[TBL] [Abstract][Full Text] [Related]
32. EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma.
Fang R; Chen X; Zhang S; Shi H; Ye Y; Shi H; Zou Z; Li P; Guo Q; Ma L; He C; Huang S
Nat Commun; 2021 Jan; 12(1):177. PubMed ID: 33420027
[TBL] [Abstract][Full Text] [Related]
33. EVI1 as a Marker for Lymph Node Metastasis in HNSCC.
Idel C; Ribbat-Idel J; Kuppler P; Krupar R; Offermann A; Vogel W; Rades D; Kirfel J; Wollenberg B; Perner S
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013033
[TBL] [Abstract][Full Text] [Related]
34. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
[TBL] [Abstract][Full Text] [Related]
35. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Nestin and EGFR in Patients with Glioblastoma Multiforme in a Public Hospital in Iran.
Matini AH; Mofidi Naeini M; Haddad Kashani H; Vakili Z
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2889-2894. PubMed ID: 33112545
[TBL] [Abstract][Full Text] [Related]
37. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
[TBL] [Abstract][Full Text] [Related]
38. [Inhibitory effects of siRNA targeting epidermal growth factor receptor on proliferation and invasion of human glioblastoma cells].
Kang CS; Pu PY; Wang GX; Li YH; Dong L; Wang H
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1503-8. PubMed ID: 15500708
[TBL] [Abstract][Full Text] [Related]
39. Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme.
Eller JL; Longo SL; Hicklin DJ; Canute GW
Neurosurgery; 2002 Oct; 51(4):1005-13; discussion 1013-4. PubMed ID: 12234411
[TBL] [Abstract][Full Text] [Related]
40. FOXC2 often overexpressed in glioblastoma enhances proliferation and invasion in glioblastoma cells.
Li W; Fu X; Liu R; Wu C; Bai J; Xu Y; Zhao Y; Xu Y
Oncol Res; 2013; 21(2):111-20. PubMed ID: 24406047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
